Prevalence of Dissociative Identity Disorder in At-risk Outpatient Groups Reporting Childhood Trauma.

NCT ID: NCT06330467

Last Updated: 2024-08-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-04

Study Completion Date

2026-08-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators will study the prevalence of dissociative identity disorder (DID) in three populations at risk in cases of childhood psychotrauma : patients with a diagnosis of borderline personality, patients with a diagnosis of functional dissociative crises (FDC) and patients with early psychosis.

The investigators will also study the prevalence of other dissociative disorders and the frequency of complex post-traumatic stress disorder.

The investigators will also look for correlations between the type of maltreatment in childhood, the age of onset of trauma and the type of diagnosis of dissociative disorders.

The investigators hope to include 150 borderline patients, 150 FDC patients and 50 early psychosis patients.

Data collection will be done via a psychometric administration of 7 self-completion questionnaires as well as the completion of the SCID-D semi-structured interview.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dissociative Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

3 groups : borderline, early psychosis and FDC.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Borderline

Borderline patients

Group Type OTHER

psychometric assessment

Intervention Type DIAGNOSTIC_TEST

Psychometric testing to assess trauma and dissociative disorders, and in particular dissociative identity disorder.

semi-structured clinical interview

Intervention Type DIAGNOSTIC_TEST

Semi-structured interview for the assessment of dissociative disorders (SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders)

Functional Dissociative Crises (FDC)

FDC patients

Group Type OTHER

psychometric assessment

Intervention Type DIAGNOSTIC_TEST

Psychometric testing to assess trauma and dissociative disorders, and in particular dissociative identity disorder.

semi-structured clinical interview

Intervention Type DIAGNOSTIC_TEST

Semi-structured interview for the assessment of dissociative disorders (SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders)

Early psychosis

Early psychosis patients : mental state at risk for psychosis and first psychotic episode

Group Type OTHER

psychometric assessment

Intervention Type DIAGNOSTIC_TEST

Psychometric testing to assess trauma and dissociative disorders, and in particular dissociative identity disorder.

semi-structured clinical interview

Intervention Type DIAGNOSTIC_TEST

Semi-structured interview for the assessment of dissociative disorders (SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

psychometric assessment

Psychometric testing to assess trauma and dissociative disorders, and in particular dissociative identity disorder.

Intervention Type DIAGNOSTIC_TEST

semi-structured clinical interview

Semi-structured interview for the assessment of dissociative disorders (SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders)

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

I-1: For all groups:

* Male or female
* Age \> or = 18
* Enrolled in or benefiting from a social security scheme
* Patient fluent in French
* Patient willing to undergo a psychological evaluation between 1h30 and 3h30
* Patient with a known history of psychotrauma in childhood before the age of 18 (sexual abuse, mistreatment, school harassment, natural disasters, attacks, etc.).
* Patient having received and understood complete information on the organization of the research and having given written free and informed consent prior to participation in the study.

I-2 : Patients in the borderline group

* Patients with main diagnosis of emotionally labile personality
* Patients with at least one psychiatric hospitalization in the last 3 years

I-3 : Patients in the early psychosis group

Patient with a diagnosis of mental state at risk of psychosis according to the criteria defined by CAARMS (Comprehensive Assessment of At Risk Mental State) OR Patients diagnosed with a first psychotic episode on an outpatient basis or following a hospital stay

I-4 : Patients in the functional dissociative crises group

Patients diagnosed with functional dissociative crises by a specialized epileptologist


* Impairment of the subject making it difficult or not impossible to participate in the trial or to understand the information provided to him/her
* Patients with specific difficulties in understanding SCID-D questions
* Psychiatric condition requiring hospitalization
* Patients with symptoms of recent toxic consumption (alcohol, cannabis, other ...) disrupting assessment responses
* Patient taking part in a pharmacological study involving a pro-dissociative molecule of the psychedelic type
* Pregnant, parturient or nursing mothers
* Person deprived of liberty by judicial or administrative decision
* Person in a life-threatening emergency
* An adult under legal protection (guardianship, curatorship, safeguard of justice)
* Person unable to give consent and not subject to a legal protection measure
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Psychothérapique de Nancy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Coraline HINGRAY

Role: PRINCIPAL_INVESTIGATOR

Centre Psychothérapique de Nancy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Psychothérapique de Nancy - CLIP

Nancy, , France

Site Status NOT_YET_RECRUITING

Centre Psychothérapique de Nancy - CMP Jacquard et Des Près

Nancy, , France

Site Status RECRUITING

CHRU Nancy - Neurology department

Nancy, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lori PETROCELLI

Role: CONTACT

+33383852377

Tatiana DABROWSKI

Role: CONTACT

+33383925349

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vincent LAPRÉVOTE

Role: primary

Coraline HINGRAY

Role: primary

Coraline HINGRAY

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RIPH 2023-02

Identifier Type: REGISTRY

Identifier Source: secondary_id

2023-A02442-43

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dissociation CBT Studies
NCT06054009 COMPLETED NA